Skip to main content
    T

    Treace Medical Concepts Inc (TMCI)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $4.04
    -0.06 (-1.46%)

    Market Cap: $262.74M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    73%(16/22)
    Avg Surprise
    -77.04%
    Streak
    10 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.25
    Range$-0.25 - $-0.25
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.23-8.7%
    60d ago$-0.24-4.2%
    30d ago$-0.24-4.2%
    7d ago$-0.24-4.2%
    Current$-0.25
    Revenue Consensus
    $48M
    Range$47M - $48M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.01
    Range$-0.02 - $0.03
    5 analysts
    Revenue Consensus
    $70M
    Range$69M - $70M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.01---
    Sep 26EST
    		-$-0.25---
    Jun 26
    Reported Aug 7
    		$-0.24$-0.30+20.00%Beat+14.3%
    Mar 26
    Reported May 8
    		$-0.28$-0.31+9.68%Beat-12.0%
    Dec 25
    Reported Feb 27
    		$-0.08$-0.15+48.52%Beat-4793.7%
    Sep 25
    Reported Nov 6
    		$-0.22$-0.27+18.52%Beat+12.0%
    Jun 25
    Reported Aug 7
    		$-0.28$-0.29+3.45%Beat+0.0%
    Mar 25
    Reported May 8
    		$-0.25$-0.30+16.67%Beat+10.7%
    Dec 24
    Reported Feb 27
    		$-0.00N/A+96.25%Beat+98.4%
    Sep 24
    Reported Nov 5
    		$-0.25$-0.26+3.85%Beat+10.7%
    Jun 24
    Reported Aug 6
    		$-0.28$-0.28+0.00%Beat-40.0%
    Mar 24
    Reported May 7
    		$-0.28$-0.31+9.68%Beat-21.7%
    Dec 23
    Reported Feb 27
    		$-0.10$-0.09-11.11%Miss-25.0%
    Sep 23
    Reported Nov 9
    		$-0.28$-0.26-7.69%Miss-27.3%
    Jun 23
    Reported Aug 8
    		$-0.20$-0.23+13.04%Beat+13.0%
    Mar 23
    Reported May 8
    		$-0.23$-0.24+4.17%Beat-43.8%
    Dec 22
    Reported Mar 7
    		$-0.08$-0.14+42.86%Beat+33.3%
    Sep 22
    Reported Nov 8
    		$-0.22$-0.29+24.14%Beat-83.3%
    Jun 22
    Reported Aug 9
    		$-0.23$-0.19-21.05%Miss-130.0%
    Mar 22
    Reported May 5
    		$-0.16$-0.17+5.88%Beat-128.6%
    Dec 21
    Reported Mar 3
    		$-0.12$-0.01-1968.97%Miss-300.0%
    Sep 21
    Reported Nov 4
    		$-0.12$-0.11-9.09%Miss-152.1%
    Jun 21
    Reported Aug 5
    		$-0.10$-0.13+23.08%Beat-
    Mar 21
    Reported Apr 26
    		$-0.07$-0.06-16.67%Miss-
    Dec 20
    Reported Mar 3
    		$0.06$0.00N/ABeat-
    Dec 19
    Reported Mar 30
    		$-0.05$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-4.94EV/EBITDAN/A
    Price/FCF-10.49xFCF Yield-9.53%
    Profitability
    Profit Margin-29.00%Operating Margin-33.00%
    ROE-72.00%ROIC-33.98%
    Financial Health
    Debt/Equity0.83xInterest Coverage-6.22x
    Current Ratio2.90xQuick Ratio1.95x
    Trading Statistics
    Beta1.49Avg Volume228.62K
    52-Week High$7.0852-Week Low$1.17

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.12
    SMA 20$4.32
    SMA 50$4.49
    SMA 200$3.14
    EMA 10$4.13
    EMA 20$4.25
    EMA 50$4.33
    EMA 200$3.93

    MACD

    Line: -0.14Signal: -0.11Hist: -0.03

    ADX

    ADX: 12.2+DI: 18.4-DI: 18.7

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down84.0
    PSAR$4.24

    Bollinger Bands

    Upper Band$4.83
    Lower Band$3.80
    %B Position2373%(Upper)
    Band Width0.23

    RSI (14-Day)

    Neutral
    40.1

    Momentum Oscillators

    Stoch %K34.4
    Stoch %D29.0
    Williams %R-69.9
    ROC (10d)-9.0%
    Momentum-0.40
    CCI (20d)-74.6
    MFI (14d)32.9

    Volatility Measures

    ATR (14d)$0.23(5.7%)
    StdDev (20d)0.26
    Hist Vol49.6%(High)

    Volume Flow

    VWAP$4.09
    OBV-3.7M
    AD Line-12.7M
    CMF (20d)-0.161

    Volume Metrics

    Avg Vol (20d)235.1K
    Vol Ratio0.9x
    VWMA (20d)$4.30

    Pivot Points

    R3$4.27
    R2$4.21
    R1$4.16
    Pivot Point$4.10
    S1$4.05
    S2$3.99
    S3$3.94

    Advanced Oscillators

    TSI-18.56
    Ultimate Osc37.0
    KST-88.52

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$45.38M$47.20M$62.52M$50.21M$47.39M$52.57M$68.71M$45.09M$44.45M$51.11M$62.21M$40.76M
    Cost of Revenue$9.77M$9.79M$12.12M$10.51M$9.63M$10.68M$13.23M$8.95M$8.78M$10.13M$11.47M$8.00M
    Gross Profit$35.61M$37.41M$50.40M$39.71M$37.75M$41.89M$55.48M$36.13M$35.67M$40.98M$50.74M$32.76M
    Operating Expenses$50.56M$54.57M$55.98M$55.29M$54.73M$57.48M$55.56M$51.25M$56.94M$59.88M$57.30M$50.55M
    R&D$4.38M$4.62M$4.54M$4.68M$5.50M$5.56M$5.21M$4.96M$5.16M$5.26M$4.15M$4.35M
    SG&A$15.25M$16.18M$14.53M$16.28M$16.14M$15.79M$13.61M$13.53M$14.22M$14.36M$13.45M$12.69M
    Operating Income$-14,958,000$-17,167,000$-5,922,000$-15,676,000$-16,974,000$-15,582,000$-204,000$-15,134,000$-21,382,000$-18,968,000$-6,782,000$-17,818,000
    Interest Income$445,000$501,000$527,000$634,000$775,000$841,000$899,000$1.07M$1.38M$1.53M$1.71M$1.57M
    Interest Expense$1.56M$1.57M$4.09M$1.34M$1.32M$1.31M$1.31M$1.31M$1.31M$1.32M$1.30M$1.30M
    Income Before Tax$-15,873,000$-17,961,000$-9,734,000$-16,380,000$-17,398,000$-15,922,000$-1,019,000$-15,380,000$-21,237,000$-18,552,000$-6,505,000$-17,544,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-15,873,000$-17,961,000$-9,394,000$-16,288,000$-17,398,000$-15,922,000$-501,000$-15,360,000$-21,206,000$-18,676,000$-6,281,000$-17,521,000
    EBITDA$-12,619,000$-15,726,000$-3,049,000$-12,828,000$-14,239,000$-12,994,000$1.88M$-13,136,000$-19,461,000$-17,121,000$-5,314,000$-16,547,000
    EBIT$-14,756,000$-16,892,000$-5,922,000$-15,676,000$-16,852,000$-15,452,000$-204,000$-15,134,000$-21,301,000$-18,770,000$-6,782,000$-17,818,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TMCI

    Government Contracts

    Gov Obligations (TTM)
    $1158
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    3
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    25,457 shares were delivered or withheld at Treace Medical (TMCI), leaving 753,226 directly held.

    Scot Michael Elder, Chief Legal & Compliance Officer and Corporate Secretary at Treace Medical Concepts, Inc. (TMCI), had 25,457 shares delivered or withheld on September 30, 2026...

    Stock Titan•10/3/26•Neutral

    Form 4 Treace Medical Concepts Inc For: 2 October By Investing.com

    This article announces the filing of Form 4 for Treace Medical Concepts Inc. on October 2nd, as reported by Investing.com. It is a brief...

    Investing.com Nigeria•10/2/26•Neutral

    Treace Medical Concepts Inc (TMCI-Q) Stock Price and News

    This page provides stock price and news updates for Treace Medical Concepts Inc (TMCI-Q). It includes real-time stock data, historical performance charts, dividend information, analyst ratings, financial reports...

    The Globe and Mail•10/2/26•Neutral

    Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock Has Consensus Target Price of $5.17 According to Brokerages

    Seven research firms have given Treace Medical Concepts (NASDAQ:TMCI) a consensus "Reduce" rating with an average 12-month price target of $5.17...

    MarketBeat•9/30/26•Neutral

    Bank of America Corp DE Acquires 3,305,100 Shares of Treace Medical Concepts, Inc. $TMCI

    Bank of America Corp DE has acquired a significant new stake of 3.31 million shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI), valued at approximately $13.15 million...

    MarketBeat•9/26/26•Neutral

    TMCI Valuation and Fair Value

    P/E
    -4.9x
    P/FCF
    -10.5x
    P/B
    3.9x
    See GNG's fair value

    TMCI Profitability: Margins, ROIC and FCF

    Gross margin
    79.5%
    Operating margin
    -33.0%
    Net margin
    -29.0%
    ROIC
    -34.0%
    ROE
    -72.0%
    FCF margin
    -12.2%
    FCF yield
    -9.5%

    TMCI Competitors

    CompanyTicker
    InfuSystems Holdings IncINFU
    Nautilus Biotechnology IncNAUT
    Anika Therapeutics IncANIK
    Standard Biotools IncLAB
    Surrozen IncSRZN
    Palisade Bio IncPALI
    Fulcrum Therapeutics IncFULC
    Prelude Therapeutics IncPRLD

    Sector: Healthcare

    TMCI Analyst Ratings

    Consensus
    Hold
    Analysts
    5
    Strong Buy
    0
    Buy
    1
    Hold
    3
    Sell
    0
    Strong Sell
    1

    TMCI Bull Case vs Bear Case

    Bull case

    • TMCI beat EPS estimates in 100.0% of its last 8 reported quarters.

    Bear case

    • TMCI has a -29.0% net profit margin.
    • TMCI's quarterly revenue changed -4.2% year over year.

    TMCI Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    27.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.25
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About TMCI

    Does TMCI pay dividends?

    Treace Medical Concepts Inc (TMCI) does not currently pay a regular dividend.

    What is TMCI's market cap?

    Treace Medical Concepts Inc (TMCI) has a market capitalization of $262.74M with a current stock price of $4.04.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In